Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 65-71

  Murwani, Retno ^a   Hodgkinson, Suzanne ^b   Armati, Patricia ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

inflammation; interferon ; interleukin 6; Schwann cells; tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL LINE; DEMYELINATING NEUROPATHY; ETIOLOGY; GUILLAIN BARRE SYNDROME; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; RATS; RATS, INBRED LEW; RNA, MESSENGER; SCHWANN CELLS; SIMIAN VIRUS 40; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344782931     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00131-2     Document Type: Article

References (44)

1. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., Peschle C. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149:1992;2358-2366.
2. + T-cell lines. J. Neuroimmunol. 40:1992;1-18.
3. Armati P.J., Pollard J.D., Gatenby P.A. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve. 113:1990;1106-1116.
4. Bansil S., Mithen F.A., Cook S.D., Sheffet A., Rohowsky-Kochan C. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome. Neurol. 41:1991;1302-1305.
5. Bansil S., Mithen F.A., Singhal B.S., Cook S.D., Rohowsky-Kochan C. Elevated neopterin levels in Guillain-Barré syndrome. Further evidence of immune activation. Arch. Neurol. 49:1992;1277-1280.
6. Benveniste E.N., Sparacio S.M., Norris J.G., Grenett H.E., Fuller G.M. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30:1990;201.
7. Berciano J., Coruci F., Monton F., Calleja J., Figols J., Lafarga M. Axonal form of Guillain-Barré Syndrome. Muscle Nerve. 16:1993;744-751.
8. Bergsteindottir K., Kingston A., Mirsky R., Jessen K. Rat Schwann cells produce interleukin-1. J. Neuroimmunol. 34:1991;15-23.
9. Bergsteindottir K., Kingston A., Mirsky R., Jessen K. Rat Schwann cell can be induced to express major histocompatibility complex class II molecules in vivo. J. Neurocytol. 21:1992;382-390.
10. Bolin L.M., Verity A.N., Silver J.E., Shooter E.M., Abrams J.S. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64:1995;850-858.
11. Brockes J., Fields K., Raff M. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve Brain Res. 165:1979;105-118.
12. Chung B.I.Y., Norris J.G., Benveniste E.N. Differential tumor necrosis factor a expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173:1991;801-811.
13. Constable A.L., Armati P.J., Toyka K.V., Hartung H. Production of the prostanoids, prostaglandin E2 and thromboxane B2 by rat Schwann cells in vitro. Brain Res. 635:1994;75-80.
14. Dyck P. Is there an axonal variety of GBS? Neurol. 41:1993;1277-1280.
15. England J.D. Guillain-Barré Syndrome. Ann. Rev. Med. 41:1990;1-6.
16. Fields K., Dammerman M. A monoclonal antibody equivalent to anti-rat neural antigen as a marker for Schwann cells. Neurosci. 15:1985;877-885.
17. Frei K., Malipiero U.V., Leisst T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689.
18. Gold R., Toyka K.V., Hartung H.P. Synergistic effect of IFNγ and TNFα on expression of immune molecules and antigen presentation by Schwann cells. Cell. Immunol. 165:1995;65-70.
19. Hartung H.-P., Hughes R.A.C., Taylor W.A., Heininger K., Reiners K., Toyka K.V. T-cell activation in Guillain-Barré syndrome and in MS: Elevated serum levels of soluble IL-2 receptors. Neurol. 40:1990;215-218.
20. Hartung H.P., Reiners K., Schmidt B., Stoll G., Toyka K.V. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann. Neurol. 30:1991;48-53.
21. Hartung, H.P. and Toyka, K.V. (1990) T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré Syndrome. Ann. Neurol. Suppl. 27, S57-63.
22. Issazadeh S., Ljungdahl A., Hojeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β J. Neuroimmunol. 61:1995;205-212.
23. Jander S., Pohl J., Gillen C., Stoll G. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J. Neurosci. Res. 43:1996;254.
24. Kingston A.E., Bergsteindottir K., Jessen K.R., van der Meide P.H., Colston M.J. Schwann cells co-cultured with stimulated T-cells and antigen express major histocompatibility (MHC) class II determinants without interferon-gamma pretreatment: Synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur. J. Immunol. 19:1989;177-183.
25. Kuhweide R., Van Damme J., Ceuppens J.L. Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth. Eur. J. Immunol. 20:1990;1019-1025.
26. Laing T.J., Weiss A. Evidence for IL-2 independent proliferation in human T cells. J. Immunol. 140:1988;1056-1062.
27. Maruo N., Morita I., Shirao M., Murota S. IL-6 increases endothelial permeability in vitro. Endocrinol. 131:1992;710-714.
28. Pollard J.D., Baverstock J., McLeod J.G. Class II antigen expression and inflammatory cells in the Guillain-Barré Syndrome. Ann. Neurol. 21:1987;337.
29. Pollard J.D., McCombe P.A., Baverstock J., Gatenby P.A., McLeod J.G. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 13:1986;123-134.
30. Racke M., Bonomo A., Scott D., Cannella B., Levine A., Raine C., Shevach E., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
31. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
32. Redford E.J., Hall S.M., Smith K.J. Vascular changes and demyelination induced by intraneural injection of tumor necrosis factor. Brain. 118:1995;869-878.
33. Samuel N.M., Mirsky R., Grange J.M., Jessen K.R. Expression of major histocompatibility complex class I and II antigens in human Schwann cell cultures and the effects of infection with Mycobacterium leprae. Clin. Exp. Immunol. 68:1987;500-509.
34. Schmidt B., Stoll G., Van der Meide P., Jung S., Hartung H.P. Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis. Brain. 115:1992;1633-1646.
35. Schneider-Schaulies J., Kirchhoff F., Archelos J., Schachner M. Down-regulation of myelin associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth. Neuron. 7:1991;995-1005.
36. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
37. Sharief M., McLean B., Thompson E. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré Syndrome. Ann. Neurol. 33:1993;591-596.
38. Shimada K., Koh C.S., Yanagisawa N. Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases. (in Japanese) Jpn. J. Allergol. 42:1993;934-940.
39. Smith K.A., Lachman L.B., Openheim J.J., Favata M.F. The functional relationship of the interleukins. J. Exp. Med. 151:1980;1551-1561.
40. Spies J., Westland K.W., Bonner J., Pollard J.D. Intraneural activated T-cells cause focal breakdown of the blood nerve barrier. Brain. 118:1995;857-868.
41. Sugiyama E., Kuroda A., Taki H., Ikemoto M., Hori T., Yamashita N., Maruyama M., Kobayashi M. Interleukin-10 cooperates with interleukin-4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J. Rheumatol. 22:1995;2020-2026.
42. Tennekoon G.I. Transfection of neonatal rat Schwann cells with SV40 large antigen gene under control of the metallothionein promotor. J. Cell Biol. 105:1987;2315-2325.
43. Wekerle H., Schwab M., Linington C., Megermouth R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur. J. Immunol. 16:1986;1551-1557.
44. Weller M., Stevens A., Sommer N., Melms A., Dichgans J., Wietholter H. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J. Neurol. Sci. 104:1991;215-221.